4//SEC Filing
Pridgen William 4
Accession 0001415889-22-007094
CIK 0001818844other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 2:08 PM ET
Size
5.2 KB
Accession
0001415889-22-007094
Insider Transaction Report
Form 4
Pridgen William
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-23+5,250→ 5,250 totalExercise: $4.23Exp: 2032-06-23→ Common Stock (5,250 underlying)
Footnotes (1)
- [F1]The stock option will vest 100% on June 23, 2023, one year following the grant date.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001826115
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 2:08 PM ET
- Size
- 5.2 KB